Targeting the Complement Pathway in Kidney Transplantation.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 14 02 2023
accepted: 02 07 2023
pmc-release: 01 11 2024
medline: 6 11 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

The complement system is paramount in the clearance of pathogens and cell debris, yet is increasingly recognized as a key component in several pathways leading to allograft injury. There is thus a growing interest in new biomarkers to assess complement activation and guide tailored therapies after kidney transplantation (KTx). C5 blockade has revolutionized post-transplant management of atypical hemolytic uremic syndrome, a paradigm of complement-driven disease. Similarly, new drugs targeting the complement amplification loop hold much promise in the treatment and prevention of recurrence of C3 glomerulopathy. Although unduly activation of the complement pathway has been described after brain death and ischemia reperfusion, any clinical attempts to mitigate the ensuing renal insults have so far provided mixed results. However, the intervention timing, strategy, and type of complement blocker need to be optimized in these settings. Furthermore, the fast-moving field of ex vivo organ perfusion technology opens new avenues to deliver complement-targeted drugs to kidney allografts with limited iatrogenic risks. Complement plays also a key role in the pathogenesis of donor-specific ABO- and HLA-targeted alloantibodies. However, C5 blockade failed overall to improve outcomes in highly sensitized patients and prevent the progression to chronic antibody-mediated rejection (ABMR). Similarly, well-conducted studies with C1 inhibitors in sensitized recipients yielded disappointing results so far, in part, because of subtherapeutic dosage used in clinical studies. The emergence of new complement blockers raises hope to significantly reduce the negative effect of ischemia reperfusion, ABMR, and nephropathy recurrence on outcomes after KTx.

Identifiants

pubmed: 37439664
doi: 10.1681/ASN.0000000000000192
pii: 00001751-202311000-00004
pmc: PMC10631604
doi:

Substances chimiques

Complement System Proteins 9007-36-7
Isoantibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1776-1792

Informations de copyright

Copyright © 2023 by the American Society of Nephrology.

Références

Clin J Am Soc Nephrol. 2020 Jan 7;15(1):109-116
pubmed: 31843975
FASEB J. 2006 Feb;20(2):217-26
pubmed: 16449793
Am J Transplant. 2016 Jan;16(1):325-33
pubmed: 26280899
Front Immunol. 2013 Jan 17;3:412
pubmed: 23335922
Blood. 2008 Sep 1;112(5):1759-66
pubmed: 18567839
Pediatr Transplant. 2018 Mar;22(2):
pubmed: 29377474
Kidney Int. 2003 Jan;63(1):134-42
pubmed: 12472776
Transplantation. 2003 Feb 15;75(3):375-82
pubmed: 12589162
Kidney Int. 2010 Jul;78(2):152-9
pubmed: 20336054
Nat Commun. 2021 Sep 15;12(1):5456
pubmed: 34526511
Kidney Int. 2016 Apr;89(4):927-38
pubmed: 26924055
Am J Transplant. 2017 Mar;17(3):682-691
pubmed: 27501352
Am J Transplant. 2011 Oct;11(10):2057-66
pubmed: 21831160
J Immunol. 2018 Dec 15;201(12):3717-3730
pubmed: 30429287
Am J Transplant. 2006 Aug;6(8):1829-40
pubmed: 16889542
Transplant Proc. 2018 Jan - Feb;50(1):66-69
pubmed: 29407333
J Am Soc Nephrol. 2017 Sep;28(9):2571-2578
pubmed: 28663231
Am J Kidney Dis. 2017 Dec;70(6):770-777
pubmed: 28821363
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F650-F657
pubmed: 31313951
Transplant Proc. 2022 Oct;54(8):2117-2124
pubmed: 36192209
Immunity. 2008 Mar;28(3):425-35
pubmed: 18328742
Kidney Int. 2019 Jul;96(1):117-128
pubmed: 31029505
Am J Pathol. 2008 Oct;173(4):973-80
pubmed: 18772341
Am J Transplant. 2018 Dec;18(12):2955-2964
pubmed: 29637714
J Am Soc Nephrol. 2006 Mar;17(3):707-15
pubmed: 16467447
J Am Soc Nephrol. 2009 Jan;20(1):197-204
pubmed: 18776120
Nat Med. 2002 Jun;8(6):582-7
pubmed: 12042808
Immunol Rev. 2014 Mar;258(1):241-58
pubmed: 24517437
J Immunol. 2017 Jun 15;198(12):4837-4845
pubmed: 28500075
FASEB J. 2017 Jul;31(7):3193-3204
pubmed: 28396344
J Am Soc Nephrol. 2012 Sep;23(9):1474-85
pubmed: 22797180
Transpl Int. 2011 Aug;24(8):e61-6
pubmed: 21696455
Am J Transplant. 2006 Sep;6(9):2099-108
pubmed: 16796725
Front Immunol. 2017 Sep 06;8:1093
pubmed: 28932227
Clin Kidney J. 2020 Oct 10;14(4):1190-1196
pubmed: 33841865
Immunity. 2021 May 11;54(5):1002-1021.e10
pubmed: 33761330
Kidney Int. 2015 Nov;88(5):1153-60
pubmed: 26221755
Am J Transplant. 2019 Oct;19(10):2876-2888
pubmed: 30887675
Transplantation. 2013 Mar 27;95(6):816-20
pubmed: 23348894
Nat Commun. 2022 Jul 26;13(1):4173
pubmed: 35882835
Transplantation. 2019 Nov;103(11):2397-2404
pubmed: 30801549
Am J Transplant. 2015 Sep;15(9):2421-30
pubmed: 25930984
Transplantation. 2013 Oct 27;96(8):739-44
pubmed: 23912175
N Engl J Med. 2022 Jul 7;387(1):35-44
pubmed: 35731912
Can J Kidney Health Dis. 2021 Mar 31;8:20543581211003763
pubmed: 33868691
Am J Transplant. 2008 Jan;8(1):86-94
pubmed: 18021283
Circ Res. 2019 Jun 7;124(12):1747-1759
pubmed: 31170059
J Am Soc Nephrol. 2016 Feb;27(2):615-25
pubmed: 26047793
Immunity. 2016 Aug 16;45(2):240-54
pubmed: 27533012
Am J Transplant. 2017 Sep;17(9):2300-2311
pubmed: 28251805
Am J Transplant. 2012 Sep;12(9):2546-53
pubmed: 22681773
J Am Soc Nephrol. 2008 Dec;19(12):2302-12
pubmed: 18753257
Kidney Int. 1979 Apr;15(4):386-95
pubmed: 390215
Blood. 2008 Feb 15;111(4):2452-61
pubmed: 18056835
Nephrol Dial Transplant. 2019 Oct 1;34(10):1780-1788
pubmed: 30844074
Am J Transplant. 2016 May;16(5):1596-603
pubmed: 26693703
Nephrol Dial Transplant. 2013 Dec;28(12):3101-9
pubmed: 24081856
Clin J Am Soc Nephrol. 2012 Nov;7(11):1843-51
pubmed: 22904122
N Engl J Med. 2022 Jul 7;387(1):79-82
pubmed: 35731913
Kidney Int Rep. 2021 Mar 25;6(6):1614-1621
pubmed: 34169201
Am J Transplant. 2012 Dec;12(12):3337-54
pubmed: 22958221
Nephron. 2020;144 Suppl 1:2-6
pubmed: 33238285
Kidney Int. 2015 Jan;87(1):182-94
pubmed: 24827778
Aging (Albany NY). 2019 Jul 8;11(13):4382-4406
pubmed: 31284268
Mol Immunol. 2011 May;48(9-10):1121-7
pubmed: 21397947
J Immunol. 2003 Feb 1;170(3):1517-23
pubmed: 12538716
Transplant Proc. 2012 Dec;44(10):3033-6
pubmed: 23195021
Transplant Proc. 2015 Jul-Aug;47(6):1754-9
pubmed: 26293046
Annu Rev Immunol. 2018 Apr 26;36:309-338
pubmed: 29677470
Am J Transplant. 2020 Feb;20(2):564-572
pubmed: 31452319
Nephrol Dial Transplant. 2011 Jul;26(7):2345-54
pubmed: 21127132
Sci Immunol. 2019 Nov 1;4(41):
pubmed: 31676497
J Allergy Clin Immunol. 2021 Apr;147(4):1420-1429.e7
pubmed: 32926878
J Exp Med. 2006 Sep 4;203(9):2165-75
pubmed: 16923853
J Immunol. 2007 Oct 1;179(7):4451-63
pubmed: 17878341
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):406-413
pubmed: 29326307
N Engl J Med. 2022 May 19;386(20):1889-1898
pubmed: 35584156
Clin J Am Soc Nephrol. 2006 Jan;1(1):88-99
pubmed: 17699195
Front Immunol. 2021 Sep 06;12:697760
pubmed: 34552582
J Clin Invest. 2018 Jan 2;128(1):219-232
pubmed: 29202467
Kidney Int. 2005 Feb;67(2):524-30
pubmed: 15673300
Clin Kidney J. 2020 Dec 15;14(8):1939-1945
pubmed: 34631043
N Engl J Med. 2018 Sep 20;379(12):1150-1160
pubmed: 30231232
Transplantation. 2016 Apr;100(4):743-52
pubmed: 26998850
Am J Transplant. 2019 Oct;19(10):2865-2875
pubmed: 31012541
Nat Immunol. 2021 Jun;22(6):757-768
pubmed: 34031614
J Clin Invest. 2014 Jun;124(6):2348-54
pubmed: 24892709
Front Immunol. 2018 May 23;9:1002
pubmed: 29875766
Am J Transplant. 2019 Jun;19(6):1671-1683
pubmed: 30412654
Transplantation. 2003 Sep 15;76(5):821-6
pubmed: 14501861
J Clin Invest. 2000 May;105(10):1363-71
pubmed: 10811844
J Am Soc Nephrol. 2018 Feb;29(2):620-635
pubmed: 29042454
N Engl J Med. 2013 Sep 26;369(13):1215-26
pubmed: 24066742
Am J Transplant. 2020 Jun;20(6):1513-1526
pubmed: 31922336
Am J Transplant. 2017 Sep;17(9):2312-2325
pubmed: 28276660
J Clin Invest. 2006 Feb;116(2):357-68
pubmed: 16444293
Trials. 2017 Jun 6;18(1):255
pubmed: 28587616
J Clin Invest. 2016 May 2;126(5):1911-25
pubmed: 27088797
Nat Rev Nephrol. 2018 Dec;14(12):767-781
pubmed: 30367174
Am J Pathol. 2004 Nov;165(5):1677-88
pubmed: 15509537
Transplantation. 2017 Oct;101(10):2410-2418
pubmed: 28926521
N Engl J Med. 2021 Mar 18;384(11):1028-1037
pubmed: 33730455
FASEB J. 2020 Jan;34(1):822-834
pubmed: 31914693
J Am Soc Nephrol. 2014 May;25(5):1110-7
pubmed: 24357668
Pediatrics. 2015 Feb;135(2):e551-5
pubmed: 25624380
Am J Transplant. 2013 Oct;13(10):2530-9
pubmed: 24033923
Front Immunol. 2019 Mar 08;10:235
pubmed: 30906289
Kidney Int. 2011 Jul;80(2):165-73
pubmed: 21544060
Am J Transplant. 2009 Jan;9(1):231-5
pubmed: 18976298
Am J Transplant. 2021 Mar;21(3):1012-1026
pubmed: 33225626
Am J Transplant. 2018 Apr;18(4):916-926
pubmed: 28980446
J Transl Med. 2016 Sep 23;14(1):277
pubmed: 27663514
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11900-11905
pubmed: 31147461
Am J Transplant. 2016 Dec;16(12):3468-3478
pubmed: 27184779
BMC Nephrol. 2016 Jan 11;17:7
pubmed: 26754737
Mol Immunol. 2020 Feb;118:142-152
pubmed: 31884386
Am J Transplant. 2009 Nov;9(11):2561-70
pubmed: 19775320
Front Immunol. 2018 May 14;9:972
pubmed: 29867953
Xenotransplantation. 2020 Jul;27(4):e12630
pubmed: 32698246
Am J Transplant. 2021 Nov;21(11):3714-3724
pubmed: 34033222
FASEB J. 2014 Sep;28(9):3996-4003
pubmed: 24868011
Vox Sang. 1989;56(3):181-6
pubmed: 2728395
Am J Transplant. 2022 Apr;22(4):1037-1053
pubmed: 35049121
Am J Transplant. 2012 Apr;12(4):877-87
pubmed: 22225993
N Engl J Med. 2006 May 11;354(19):2014-23
pubmed: 16687714
J Am Soc Nephrol. 2019 Dec;30(12):2449-2463
pubmed: 31575699
Am J Pathol. 2003 Oct;163(4):1457-65
pubmed: 14507653
Nephrol Dial Transplant. 1999 Jul;14(7):1723-31
pubmed: 10435883
Transplantation. 2006 Mar 15;81(5):665-71
pubmed: 16534466
Am J Transplant. 2013 Mar;13(3):663-75
pubmed: 23356914
J Am Soc Nephrol. 2015 Feb;26(2):457-67
pubmed: 25125383
Transplantation. 2014 Oct 27;98(8):857-63
pubmed: 25121475
J Immunol. 2007 Feb 1;178(3):1819-28
pubmed: 17237432
Am J Pathol. 2010 Apr;176(4):1648-59
pubmed: 20150432
Case Rep Transplant. 2016;2016:9874261
pubmed: 27478676
Am J Transplant. 2011 Nov;11(11):2405-13
pubmed: 21942930
J Clin Invest. 2012 Oct;122(10):3647-51
pubmed: 22996693
Am J Transplant. 2015 May;15(5):1293-302
pubmed: 25731800
Front Immunol. 2019 Dec 20;10:2975
pubmed: 31921212
Immunity. 2012 Aug 24;37(2):199-207
pubmed: 22921118
Am J Transplant. 2014 Feb;14(2):272-83
pubmed: 24472190
Transplantation. 2015 Feb;99(2):299-308
pubmed: 25606785
Kidney Int. 1994 Jul;46(1):89-96
pubmed: 7523758
Am J Kidney Dis. 2019 Mar;73(3):316-323
pubmed: 30413277

Auteurs

Dela Golshayan (D)

Transplantation Center , Department of Medicine , Lausanne University Hospital and University of Lausanne , Lausanne , Switzerland.

Nora Schwotzer (N)

Service of Nephrology and Hypertension, Department of Medicine , Lausanne University Hospital and University of Lausanne , Lausanne , Switzerland.

Fadi Fakhouri (F)

Service of Nephrology and Hypertension, Department of Medicine , Lausanne University Hospital and University of Lausanne , Lausanne , Switzerland.

Julien Zuber (J)

Service de Transplantation rénale adulte, Assistance Publique-Hôpitaux de Paris , Hôpital Necker , Paris , France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH